These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 12542194)
21. Laboratory and field evaluation of Teknar HP-D, a biolarvicidal formulation of Bacillus thuringiensis ssp. israelensis, against mosquito vectors. Gunasekaran K; Doss PS; Vaidyanathan K Acta Trop; 2004 Oct; 92(2):109-18. PubMed ID: 15350862 [TBL] [Abstract][Full Text] [Related]
22. Field evaluation against Aedes aegypti larvae of aluminum-carboxymethylcellulose-encapsulated spore-toxin complex formulation of Bacillus thuringiensis serovar israelensis. Aguilar-Meza O; Ramírez-Suero M; Bernal JS; Ramírez-Lepe M J Econ Entomol; 2010 Jun; 103(3):570-6. PubMed ID: 20568600 [TBL] [Abstract][Full Text] [Related]
23. Factors influencing the activity of Bacillus thuringiensis var. israelensis treatments. Becker N; Zgomba M; Ludwig M; Petric D; Rettich F J Am Mosq Control Assoc; 1992 Sep; 8(3):285-9. PubMed ID: 1357088 [TBL] [Abstract][Full Text] [Related]
24. Procedures for the evaluation of field efficacy of slow-release formulations of larvicides against Aedes aegypti in water-storage containers. Mulla MS; Thavara U; Tawatsin A; Chompoosri J J Am Mosq Control Assoc; 2004 Mar; 20(1):64-73. PubMed ID: 15088706 [TBL] [Abstract][Full Text] [Related]
25. Efficacy of Bacillus thuringiensis israelensis, VectoBac WG and DT, formulations against dengue mosquito vectors in cement potable water jars in Cambodia. Setha T; Chantha N; Socheat D Southeast Asian J Trop Med Public Health; 2007 Mar; 38(2):261-8. PubMed ID: 17539275 [TBL] [Abstract][Full Text] [Related]
26. Efficacy of Czechoslovak and Soviet Bacillus thuringiensis (serotype H-14) formulations against mosquito larvae. Rettich F J Hyg Epidemiol Microbiol Immunol; 1987; 31(1):53-63. PubMed ID: 2883232 [TBL] [Abstract][Full Text] [Related]
27. Susceptibility of field-collected Aedes aegypti (L.) (Diptera: Culicidae) to Bacillus thuringiensis israelensis and temephos. Loke SR; Andy-Tan WA; Benjamin S; Lee HL; Sofian-Azirun M Trop Biomed; 2010 Dec; 27(3):493-503. PubMed ID: 21399591 [TBL] [Abstract][Full Text] [Related]
28. Immobilization in alginate as a technique for the preservation of Bacillus thuringiensis var. israelensis for long-term preservation. Prabakaran G; Hoti SL J Microbiol Methods; 2008 Jan; 72(1):91-4. PubMed ID: 18054810 [TBL] [Abstract][Full Text] [Related]
29. Residual activity of Bacillus thuringiensis serovars medellin and jegathesan on Culex pipiens and Aedes aegypti larvae. Thiéry I; Fouque F; Gaven B; Lagneau C J Am Mosq Control Assoc; 1999 Sep; 15(3):371-9. PubMed ID: 10480130 [TBL] [Abstract][Full Text] [Related]
30. Spray-dried Bacillus thuringiensis Serovar israelensis formulations for control of Aedes aegypti larvae. Ramírez-Suero M; Robles-Olvera V; Ramírez-Lepe M J Econ Entomol; 2005 Oct; 98(5):1494-8. PubMed ID: 16334315 [TBL] [Abstract][Full Text] [Related]
31. Larvicidal activity and influence of Bacillus thuringiensis var. israelensis on Aedes albopictus oviposition in ovitraps during a two-week check interval protocol. Carrieri M; Masetti A; Albieri A; Maccagnani B; Bellini R J Am Mosq Control Assoc; 2009 Jun; 25(2):149-55. PubMed ID: 19653496 [TBL] [Abstract][Full Text] [Related]
32. Differential efficacy evaluation of formulations of Bacillus thuringiensis Var israelensis against mosquitoes: a laboratory investigation. Srivastava R; Tilak VW Indian J Public Health; 1999; 43(4):152-5. PubMed ID: 11243064 [TBL] [Abstract][Full Text] [Related]
33. Laboratory and simulated field evaluation of a new recombinant of Bacillus thuringiensis ssp. israelensis and Bacillus sphaericus against Culex mosquito larvae (Diptera: Culicidae). Zahiri NS; Federici BA; Mulla MS J Med Entomol; 2004 May; 41(3):423-9. PubMed ID: 15185945 [TBL] [Abstract][Full Text] [Related]
34. Control of mosquito larvae by encapsulated pathogen Bacillus thuringiensis var. israelensis. Elçin YM J Microencapsul; 1995; 12(5):515-23. PubMed ID: 8544095 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of two formulations of Bacillus thuringiensis var. israelensis (H-14) against Aedes vexans and safety to non-target macroinvertebrates. Gharib AH; Hilsenhoff WL J Am Mosq Control Assoc; 1988 Sep; 4(3):252-5. PubMed ID: 3199115 [TBL] [Abstract][Full Text] [Related]
36. Host range and selected factors influencing the mosquito larvicidal activity of the PG-14 isolate of Bacillus thuringiensis var. morrisoni. Lacey LA; Lacey CM; Padua LE J Am Mosq Control Assoc; 1988 Mar; 4(1):39-43. PubMed ID: 3193097 [TBL] [Abstract][Full Text] [Related]
37. Sterilization of Bacillus thuringiensis israelensis products by gamma radiation. Becker N J Am Mosq Control Assoc; 2002 Mar; 18(1):57-62. PubMed ID: 11998932 [TBL] [Abstract][Full Text] [Related]
38. Novel larvicide tablets of Bacillus thuringiensis var. israelensis: Assessment of larvicidal effect on Aedes aegypti (Diptera: Culicidae) in Colombia. Gómez-Vargas W; Valencia-Jiménez K; Correa-Londoño G; Jaramillo-Yepes F Biomedica; 2018 Aug; 38(0):95-105. PubMed ID: 30184370 [TBL] [Abstract][Full Text] [Related]
39. Long-term effects of Bacillus thuringiensis subsp. israelensis on Aedes aegypti. Ceianu C Roum Arch Microbiol Immunol; 1991; 50(1):61-6. PubMed ID: 1802053 [TBL] [Abstract][Full Text] [Related]
40. Development of a self floating slow release formulation of Bacillus thuringiensis var. israelensis and its larvicidal activity. Prabakaran G; Padmanabhan V; Balaraman K Indian J Exp Biol; 2001 Jan; 39(1):82-4. PubMed ID: 11349533 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]